The grant will help other colleges and universities implement the types of innovative, evidence-based strategies that have made Georgia State a national model for student success.
The Center for Translational Antiviral Research has been established in the Institute for Biomedical Sciences at Georgia State University to fill the gap for developing affordable, much-needed antiviral drugs that will reduce severe viral diseases and meet the threats imposed by existing and newly evolving viruses.
Scientists in the Institute for Biomedical Sciences have shed light on how cells can slow replication of the Ebola virus, preventing infection. “We hope these findings will enable us to develop new ways to prevent or treat Ebola.”
The new name reflects the interests and academic needs of an increasingly diverse student population with a strong interest in international, cross-cultural scholarship.
Georgia State will be responsible for the learning analytics portion of the project, a collaborative effort by Georgia universities and other partners.
Georgia State University faculty have earned $142 million in research funding in fiscal year 2021, the third highest total in university history.
Georgia State’s economic impact on Georgia is nearly $2.8 billion, according to new economic data released by the University System of Georgia in a report that highlights the economic benefits of the state’s higher education institutions.
Compounds targeting two key enzymes are potent inhibitors of SARS-CoV-2, the virus that causes COVID-19, according to a study led by the Institute for Biomedical Sciences at Georgia State.
More than 10,000 donors contributed during the year and helped the university surpass its previous one-year fundraising record of $51.2 million set in 2017.
Funded with grants from JPMorgan Chase, the CINEMA Program operated by Georgia State’s Alonzo A. Crim Center for Urban Educational Excellence is building the next generation of Atlanta’s film, television and digital arts workforce.
